2023-507409-32-00已完成1 期
A study to investigate the safety, pharmacodynamics and pharmacokinetics of increasing doses of subcutaneously administered deuterated DMT (CYB004) in healthy subjects
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 72
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
A. House-Gecewicz
Scientific
Cybin IRL Limited
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
A study to investigate the safety, pharmacodynamics and pharmacokinetics of increasing doses of subcutaneously administered deuterated DMT (CYB004) in healthy subjectsCTIS2023-507409-32-00Cybin IRL Limited72
进行中（未招募）
不适用
A study to investigate the safety, pharmacokinetics, occurrence of anti-drug antibody, and anti-RSV neutralizing antibody following 2 doses administration of nirsevimab (MEDI8897) in infants with certain health conditions or born pre-term in Japan (JUBILUS)jRCT2031230256AstraZeneca AB33
未知
2 期
A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis who are Direct Acting Antiviral Treatment-naivejRCT2080223413Janssen Pharmaceutical K.K.40
已完成
不适用
A study to investigate the pharmacodynamics, safety and tolerability of cutaneous capsaicin in healthy adult subjects.Small fibre neuropathy10034606NL-OMON37233Centre for Human Drug Research12
招募中
1 期
A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AZD8630, Administered Once Daily via Inhalation, for 2 Weeks, in Adults with Asthma on Medium-to-high Dose Inhaled Corticosteroids and Long-acting Beta-agonistsAsthma2024-514213-35-00AstraZeneca AB24